Variant report
Variant | esv3392200 |
---|---|
Chromosome Location | chr5:1408802-1411300 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1407993..1411538-chr5:1413820..1417067,3 | K562 | blood: | |
2 | chr5:1409153..1410840-chr5:1412800..1414912,2 | K562 | blood: | |
3 | chr5:1410300..1412091-chr5:1499870..1502587,2 | MCF-7 | breast: | |
4 | chr5:1406843..1410156-chr5:1456046..1458369,3 | MCF-7 | breast: | |
5 | chr5:1408393..1412171-chr5:1413541..1415179,3 | MCF-7 | breast: | |
6 | chr5:1404571..1406990-chr5:1408962..1411228,2 | MCF-7 | breast: | |
7 | chr5:1403700..1406168-chr5:1408661..1411509,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000142319 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541560375 | chr5:1408841-1408842 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs56719408 | chr5:1408847-1408848 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs368867376 | chr5:1408880-1408881 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs28363109 | chr5:1408897-1408898 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs564810404 | chr5:1408906-1408907 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs117275738 | chr5:1408945-1408946 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs11133770 | chr5:1408979-1408980 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs534459203 | chr5:1409012-1409013 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs149407403 | chr5:1409016-1409017 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs529389248 | chr5:1409040-1409041 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs553141529 | chr5:1409068-1409069 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs551121480 | chr5:1409081-1409082 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs34128392 | chr5:1409083-1409084 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs556622482 | chr5:1409087-1409088 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs8179032 | chr5:1409109-1409110 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs576122531 | chr5:1409113-1409114 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs8179033 | chr5:1409114-1409115 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs111306562 | chr5:1409127-1409128 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs558546637 | chr5:1409128-1409129 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs8179034 | chr5:1409169-1409170 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs147974193 | chr5:1409171-1409172 | Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs373567571 | chr5:1409220-1409221 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs8179035 | chr5:1409226-1409227 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs75916702 | chr5:1409228-1409229 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs373232140 | chr5:1409259-1409260 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs376531914 | chr5:1409277-1409278 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs546373953 | chr5:1409299-1409300 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs536097059 | chr5:1409317-1409318 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs567943679 | chr5:1409329-1409330 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs199589538 | chr5:1409340-1409341 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs535174431 | chr5:1409356-1409357 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs146180782 | chr5:1409374-1409375 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs575930083 | chr5:1409436-1409437 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs377115546 | chr5:1409459-1409460 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs574853765 | chr5:1409460-1409461 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs113121109 | chr5:1409480-1409481 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs73030138 | chr5:1409482-1409483 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs148590368 | chr5:1409502-1409503 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs28363108 | chr5:1409528-1409529 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs540602356 | chr5:1409577-1409578 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs562242794 | chr5:1409692-1409693 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs28363107 | chr5:1409693-1409694 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs2245660 | chr5:1409719-1409720 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs562976050 | chr5:1409720-1409721 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs533148704 | chr5:1409740-1409741 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs28363106 | chr5:1409741-1409742 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs150541873 | chr5:1409773-1409774 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs560319669 | chr5:1409776-1409777 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs528367688 | chr5:1409778-1409779 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs112121702 | chr5:1409779-1409780 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung squamous cell carcinoma | 22363434 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Intellectual disability | 22102821 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
Ovarian cancer | 21720365 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Epilepsy | 20502679 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Schizophrenia | 21346763 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1408600-1409000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr5:1408600-1409800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr5:1408800-1409600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr5:1408800-1410000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:1409000-1409200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
6 | chr5:1409000-1409200 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr5:1409000-1409200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr5:1409000-1409600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr5:1409200-1409800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr5:1409600-1413000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr5:1410000-1412400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr5:1410400-1410600 | Bivalent Enhancer | Placenta | Placenta |
13 | chr5:1410600-1411000 | ZNF genes & repeats | Spleen | Spleen |
14 | chr5:1411000-1412400 | Weak transcription | Spleen | Spleen |